HEADER IMMUNE SYSTEM 22-APR-20 6WNA TITLE NEXT GENERATION MONOMERIC IGG4 FC COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG RECEPTOR FCRN LARGE SUBUNIT P51; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR REGION; COMPND 5 SYNONYM: FCRN,IGG FC FRAGMENT RECEPTOR TRANSPORTER ALPHA CHAIN, COMPND 6 NEONATAL FC RECEPTOR; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4; COMPND 14 CHAIN: H; COMPND 15 FRAGMENT: DOMAINS CH2 AND CH3; COMPND 16 SYNONYM: IG GAMMA-4 CHAIN C REGION; COMPND 17 ENGINEERED: YES; COMPND 18 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FCGRT, FCRN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: IGHG4; SOURCE 20 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ANTIBODY CONSTANT REGION, FRAGMENT CRYSTALLIZABLE, MUTATED, IMMUNE KEYWDS 2 SYSTEM, NEONATAL RECEPTOR INTERACTION, HALF-LIFE EXPDTA X-RAY DIFFRACTION AUTHOR V.Y.OGANESYAN,L.SHAN,N.VAN DYK,W.F.DALL'ACQUA REVDAT 3 18-OCT-23 6WNA 1 REMARK REVDAT 2 22-SEP-21 6WNA 1 JRNL REVDAT 1 15-SEP-21 6WNA 0 JRNL AUTH L.SHAN,N.V.DYK,N.HASKINS,K.M.COOK,K.L.ROSENTHAL,R.MAZOR, JRNL AUTH 2 S.DRAGULIN-OTTO,Y.JIANG,H.WU,W.F.DALL'ACQUA,M.J.BORROK, JRNL AUTH 3 M.M.DAMSCHRODER,V.OGANESYAN JRNL TITL IN VIVO PHARMACOKINETIC ENHANCEMENT OF MONOMERIC FC AND JRNL TITL 2 MONOVALENT BISPECIFIC DESIGNS THROUGH STRUCTURAL GUIDANCE. JRNL REF COMMUN BIOL V. 4 1048 2021 JRNL REFN ESSN 2399-3642 JRNL PMID 34497355 JRNL DOI 10.1038/S42003-021-02565-5 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 28605 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 876 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2051 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.44 REMARK 3 BIN R VALUE (WORKING SET) : 0.3230 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4530 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 88 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.27000 REMARK 3 B22 (A**2) : 2.90000 REMARK 3 B33 (A**2) : -0.63000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.363 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.260 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.206 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.142 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4787 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4228 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6512 ; 1.841 ; 1.685 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9896 ; 1.152 ; 1.604 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 558 ; 7.823 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 250 ;33.530 ;22.760 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 768 ;17.126 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;22.701 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 613 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5235 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1005 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6WNA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248659. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29521 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.14900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 1.26100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5HVW, 4N0U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE, REMARK 280 30% 1,5-DIAMINOPENTANE DIHYDROCHLORIDE, 0.1 M MES, PH 6 AND 20% REMARK 280 PEG 6000 AT A PROTEIN CONCENTRATION OF 6 MG/ML, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.72300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 89.72300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.04750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.04800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.04750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.04800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.72300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.04750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 61.04800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.72300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.04750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 61.04800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 267 REMARK 465 GLN H 268 REMARK 465 GLU H 269 REMARK 465 ASP H 270 REMARK 465 LYS H 326 REMARK 465 GLY H 327 REMARK 465 LEU H 328 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O6 NAG C 1 O2 FUC C 9 1.48 REMARK 500 O6 NAG C 1 C2 FUC C 9 1.53 REMARK 500 C6 NAG C 1 C1 FUC C 9 1.63 REMARK 500 SG CYS A 48 O HOH A 334 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 19 123.07 -35.70 REMARK 500 ASN A 55 76.20 -61.41 REMARK 500 ASP A 101 51.53 -97.43 REMARK 500 ALA A 108 77.92 -153.63 REMARK 500 ASN A 113 51.43 37.01 REMARK 500 PHE A 117 -13.90 -144.63 REMARK 500 PHE A 157 -66.13 -100.84 REMARK 500 SER A 189 -84.31 -109.82 REMARK 500 PRO B 32 -169.42 -77.32 REMARK 500 TRP B 60 -8.72 80.91 REMARK 500 ASP H 265 64.96 64.02 REMARK 500 GLU H 356 -47.86 143.18 REMARK 500 THR H 359 82.13 -64.69 REMARK 500 PRO H 374 -169.15 -76.99 REMARK 500 PRO H 387 152.40 -48.78 REMARK 500 LEU H 406 148.70 -174.92 REMARK 500 REMARK 500 REMARK: NULL DBREF 6WNA A 4 267 UNP P55899 FCGRN_HUMAN 27 290 DBREF 6WNA B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 6WNA H 238 444 UNP P01861 IGHG4_HUMAN 118 324 SEQADV 6WNA TYR H 252 UNP P01861 MET 132 ENGINEERED MUTATION SEQADV 6WNA THR H 254 UNP P01861 SER 134 ENGINEERED MUTATION SEQADV 6WNA GLU H 256 UNP P01861 THR 136 ENGINEERED MUTATION SEQADV 6WNA PHE H 351 UNP P01861 LEU 231 ENGINEERED MUTATION SEQADV 6WNA GLU H 354 UNP P01861 SER 234 ENGINEERED MUTATION SEQADV 6WNA ARG H 366 UNP P01861 THR 246 ENGINEERED MUTATION SEQADV 6WNA LYS H 395 UNP P01861 PRO 275 ENGINEERED MUTATION SEQADV 6WNA ARG H 405 UNP P01861 PHE 285 ENGINEERED MUTATION SEQADV 6WNA GLU H 407 UNP P01861 TYR 287 ENGINEERED MUTATION SEQRES 1 A 264 HIS LEU SER LEU LEU TYR HIS LEU THR ALA VAL SER SER SEQRES 2 A 264 PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SER GLY TRP SEQRES 3 A 264 LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SER LEU ARG SEQRES 4 A 264 GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL TRP GLU ASN SEQRES 5 A 264 GLN VAL SER TRP TYR TRP GLU LYS GLU THR THR ASP LEU SEQRES 6 A 264 ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA PHE LYS ALA SEQRES 7 A 264 LEU GLY GLY LYS GLY PRO TYR THR LEU GLN GLY LEU LEU SEQRES 8 A 264 GLY CYS GLU LEU GLY PRO ASP ASN THR SER VAL PRO THR SEQRES 9 A 264 ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE MET ASN PHE SEQRES 10 A 264 ASP LEU LYS GLN GLY THR TRP GLY GLY ASP TRP PRO GLU SEQRES 11 A 264 ALA LEU ALA ILE SER GLN ARG TRP GLN GLN GLN ASP LYS SEQRES 12 A 264 ALA ALA ASN LYS GLU LEU THR PHE LEU LEU PHE SER CYS SEQRES 13 A 264 PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG GLY ARG GLY SEQRES 14 A 264 ASN LEU GLU TRP LYS GLU PRO PRO SER MET ARG LEU LYS SEQRES 15 A 264 ALA ARG PRO SER SER PRO GLY PHE SER VAL LEU THR CYS SEQRES 16 A 264 SER ALA PHE SER PHE TYR PRO PRO GLU LEU GLN LEU ARG SEQRES 17 A 264 PHE LEU ARG ASN GLY LEU ALA ALA GLY THR GLY GLN GLY SEQRES 18 A 264 ASP PHE GLY PRO ASN SER ASP GLY SER PHE HIS ALA SER SEQRES 19 A 264 SER SER LEU THR VAL LYS SER GLY ASP GLU HIS HIS TYR SEQRES 20 A 264 CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA GLN PRO LEU SEQRES 21 A 264 ARG VAL GLU LEU SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 H 207 PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP THR SEQRES 2 H 207 LEU TYR ILE THR ARG GLU PRO GLU VAL THR CYS VAL VAL SEQRES 3 H 207 VAL ASP VAL SER GLN GLU ASP PRO GLU VAL GLN PHE ASN SEQRES 4 H 207 TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS THR SEQRES 5 H 207 LYS PRO ARG GLU GLU GLN PHE ASN SER THR TYR ARG VAL SEQRES 6 H 207 VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU ASN SEQRES 7 H 207 GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS GLY LEU SEQRES 8 H 207 PRO SER SER ILE GLU LYS THR ILE SER LYS ALA LYS GLY SEQRES 9 H 207 GLN PRO ARG GLU PRO GLN VAL TYR THR PHE PRO PRO GLU SEQRES 10 H 207 GLN GLU GLU MET THR LYS ASN GLN VAL SER LEU ARG CYS SEQRES 11 H 207 LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL GLU SEQRES 12 H 207 TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS THR SEQRES 13 H 207 THR LYS PRO VAL LEU ASP SER ASP GLY SER PHE ARG LEU SEQRES 14 H 207 GLU SER ARG LEU THR VAL ASP LYS SER ARG TRP GLN GLU SEQRES 15 H 207 GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA LEU SEQRES 16 H 207 HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET GAL C 6 11 HET MAN C 7 11 HET NAG C 8 14 HET FUC C 9 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 MAN 2(C6 H12 O6) FORMUL 4 GAL C6 H12 O6 FORMUL 4 FUC C6 H12 O5 FORMUL 5 HOH *88(H2 O) HELIX 1 AA1 GLY A 49 GLU A 54 5 6 HELIX 2 AA2 TRP A 59 GLY A 83 1 25 HELIX 3 AA3 TRP A 131 GLN A 144 1 14 HELIX 4 AA4 LYS A 146 PHE A 157 1 12 HELIX 5 AA5 PHE A 157 GLY A 170 1 14 HELIX 6 AA6 GLY A 170 TRP A 176 1 7 HELIX 7 AA7 ASP A 246 HIS A 248 5 3 HELIX 8 AA8 LYS H 246 TYR H 252 1 7 HELIX 9 AA9 LEU H 309 ASN H 315 1 7 HELIX 10 AB1 LYS H 414 GLU H 419 1 6 HELIX 11 AB2 LEU H 432 ASN H 434 5 3 SHEET 1 AA1 8 GLU A 46 PRO A 47 0 SHEET 2 AA1 8 GLN A 33 ASN A 39 -1 N SER A 37 O GLU A 46 SHEET 3 AA1 8 PHE A 24 LEU A 30 -1 N VAL A 26 O TYR A 38 SHEET 4 AA1 8 SER A 6 VAL A 14 -1 N HIS A 10 O SER A 27 SHEET 5 AA1 8 THR A 89 GLY A 99 -1 O LEU A 94 N TYR A 9 SHEET 6 AA1 8 THR A 103 LEU A 112 -1 O THR A 103 N GLY A 99 SHEET 7 AA1 8 GLU A 115 ASP A 121 -1 O MET A 118 N PHE A 110 SHEET 8 AA1 8 THR A 126 GLY A 128 -1 O THR A 126 N ASP A 121 SHEET 1 AA2 4 SER A 181 PRO A 188 0 SHEET 2 AA2 4 PHE A 193 PHE A 203 -1 O SER A 199 N ARG A 183 SHEET 3 AA2 4 PHE A 234 LYS A 243 -1 O LEU A 240 N LEU A 196 SHEET 4 AA2 4 GLN A 223 PRO A 228 -1 N GLY A 227 O HIS A 235 SHEET 1 AA3 4 LEU A 217 ALA A 218 0 SHEET 2 AA3 4 LEU A 208 ARG A 214 -1 N ARG A 214 O LEU A 217 SHEET 3 AA3 4 TYR A 250 HIS A 256 -1 O ILE A 253 N ARG A 211 SHEET 4 AA3 4 LEU A 263 GLU A 266 -1 O VAL A 265 N CYS A 252 SHEET 1 AA4 4 LYS B 6 SER B 11 0 SHEET 2 AA4 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA4 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 AA4 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AA5 4 LYS B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 AA5 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA6 4 GLU B 44 ARG B 45 0 SHEET 2 AA6 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AA6 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 AA6 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SHEET 1 AA7 4 SER H 239 PHE H 243 0 SHEET 2 AA7 4 GLU H 258 VAL H 266 -1 O VAL H 264 N SER H 239 SHEET 3 AA7 4 TYR H 300 THR H 307 -1 O VAL H 302 N VAL H 263 SHEET 4 AA7 4 LYS H 288 THR H 289 -1 N LYS H 288 O VAL H 305 SHEET 1 AA8 4 SER H 239 PHE H 243 0 SHEET 2 AA8 4 GLU H 258 VAL H 266 -1 O VAL H 264 N SER H 239 SHEET 3 AA8 4 TYR H 300 THR H 307 -1 O VAL H 302 N VAL H 263 SHEET 4 AA8 4 GLU H 293 GLU H 294 -1 N GLU H 293 O ARG H 301 SHEET 1 AA9 4 VAL H 282 VAL H 284 0 SHEET 2 AA9 4 GLN H 274 VAL H 279 -1 N VAL H 279 O VAL H 282 SHEET 3 AA9 4 TYR H 319 SER H 324 -1 O LYS H 322 N ASN H 276 SHEET 4 AA9 4 ILE H 332 ILE H 336 -1 O ILE H 336 N TYR H 319 SHEET 1 AB1 4 GLN H 347 PHE H 351 0 SHEET 2 AB1 4 GLN H 362 PHE H 372 -1 O LYS H 370 N GLN H 347 SHEET 3 AB1 4 PHE H 404 ASP H 413 -1 O LEU H 410 N LEU H 365 SHEET 4 AB1 4 TYR H 391 THR H 393 -1 N LYS H 392 O ARG H 409 SHEET 1 AB2 4 GLN H 347 PHE H 351 0 SHEET 2 AB2 4 GLN H 362 PHE H 372 -1 O LYS H 370 N GLN H 347 SHEET 3 AB2 4 PHE H 404 ASP H 413 -1 O LEU H 410 N LEU H 365 SHEET 4 AB2 4 VAL H 397 LEU H 398 -1 N VAL H 397 O ARG H 405 SHEET 1 AB3 4 GLN H 386 GLU H 388 0 SHEET 2 AB3 4 ALA H 378 SER H 383 -1 N SER H 383 O GLN H 386 SHEET 3 AB3 4 PHE H 423 MET H 428 -1 O MET H 428 N ALA H 378 SHEET 4 AB3 4 TYR H 436 LEU H 441 -1 O LEU H 441 N PHE H 423 SSBOND 1 CYS A 96 CYS A 159 1555 1555 2.10 SSBOND 2 CYS A 198 CYS A 252 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.02 SSBOND 4 CYS H 261 CYS H 321 1555 1555 2.03 SSBOND 5 CYS H 367 CYS H 425 1555 1555 2.03 LINK ND2 ASN H 297 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O6 NAG C 1 C1 FUC C 9 1555 1555 1.35 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.45 LINK O3 BMA C 3 C1 MAN C 7 1555 1555 1.44 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.43 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.45 LINK O2 MAN C 7 C1 NAG C 8 1555 1555 1.44 CISPEP 1 TYR A 204 PRO A 205 0 -1.90 CISPEP 2 HIS B 31 PRO B 32 0 4.30 CISPEP 3 TYR H 373 PRO H 374 0 -2.44 CRYST1 68.095 122.096 179.446 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014685 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005573 0.00000